Search clinical trials for: AMPLATZER™ PFO Occluder

Total 103 results

Abbott Medical Devices

Recruiting

AMPLATZER PFO Occluder Post Approval Study (PFO PAS)

Stroke | Patent Foramen Ovale

United States, Germany, Canada, Switzerland, Italy, Portugal, United Kingdom
Abbott Medical Devices

Recruiting

Trevisio Post-Approval Study (TrevisioPAS)

PFO - Patent Foramen Ovale | VSD - Muscular Ventricular Septal Defect | PIVSD - Post Infarct Muscular Ventricular Septal Defect | ASD - Atrial Septal Defect

Spain, Germany, Poland, France, Italy, Netherlands, Switzerland
Abbott Medical Devices

Active, not recruiting

Amplatzer PFO Occluder Post-marketing Surveillance Study (PFO PMS Jpn)

PFO - Patent Foramen Ovale

Japan
Nobles Medical Technologies II Inc

Suspended

NobleStitch EL STITCH Trial is a PFO Comparative Trial (STITCH)

Foramen Ovale, Patent | Stroke, Ischemic

United States, Italy
Abbott Medical Devices

Completed

PREMIUM Migraine Trial

Patent Foramen Ovale | Migraine Headaches

United States
Abbott Medical Devices

Terminated

PRIMA PFO Migraine Trial (PRIMA)

Migraine | Patent Foramen Ovale | Migraine With Aura | PFO

United Kingdom, Germany, Canada, Switzerland
Abbott Medical Devices

Completed

AMPLATZER™ LAA Occluder Post Approval Study (PAS)

Stroke | Atrial Fibrillation | Thromboembolism

Canada, Italy, Spain, Argentina, Belgium, Chile, Germany
Abbott Medical Devices

Approved for marketing

Emergency/Compassionate Use PFO Occluder

Patent Foramen Ovale | PFO
Abbott Medical Devices

No longer available

PFO ACCESS Registry

Stroke | Patent Foramen Ovale
Abbott Medical Devices

Completed

The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) Post Approval Study (PIVSD PAS)

Post-Infarction Ventricular Septal Defect

United States
University Health Network, Toronto
St. Paul's Hospital, Canada; Montreal Heart Institute; Centre de Recherche de...

Recruiting

Comparison of Devices for Atrial Septal Defects Closure: A Pilot Study (Trio-ASD)

Atrial Septal Defect

Canada
Abbott Medical Devices
Japanese society of Congenital Interventional Cardiology

Recruiting

Amplatzer Piccolo Occluder Japan Post-marketing Database Surveillance

Patent Ductus Arteriosus

Japan
Lifetech Scientific (Shenzhen) Co., Ltd.

Recruiting

Lifetech Cera™ PFO Occluder Post-Market Clinical Follow-Up

Patent Foramen Ovale | PFO

Poland
Nobles Medical Technologies II Inc

Enrolling by invitation

Stitch Closure of PFO and Septal Repair (STITCH)

Foramen Ovale, Patent | Septal Defect, Atrial | Septal Defect, Heart

United States, Italy
Abbott Medical Devices

Terminated

ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study (ASO 522)

Atrial Septal Defect Secundum

United States
Abbott Medical Devices

Completed

Closure of Perimembranous Ventricular Septal Defects With The AMPLATZER® Membranous VSD OCCLUDER

Membranous Ventricular Septal Defects

United States
Abbott Medical Devices

Completed

Closure of Atrial Septal Defects With the AMPLATZER Septal Occluder - Post Approval Study

Atrial Septal Defect

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Transcaval Access for Transcatheter Aortic Valve Replacement in People With No Good Options for Aortic Access

Aortic Valve Stenosis

United States
Gachon University Gil Medical Center

Completed

Residual Shunt After Patent Foramen Ovale Device Closure in Patients With Cryptogenic Stroke

Patent Foramen Ovale | Closure; Foramen Ovale

Korea, Republic of
Abbott Medical Devices

Completed

AMPLATZER Duct Occluder II Clinical Study (ADO II)

Patent Ductus Arteriosus

United States
Abbott Medical Devices

Approved for marketing

Emergency/Compassionate Use - Muscular VSD Occluder

Ventricular | Septal | Defects | VSD | Muscular
Abbott Medical Devices

Active, not recruiting

Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval Study (VPA)

Ventricular Septal Defects

United States, Canada
Abbott Medical Devices

No longer available

Emergency/Compassionate Use - AMPLATZER Duct Occluder

Patent | Ductus | Arteriosus
Abbott Medical Devices

Recruiting

Amplatzer Amulet LAAO vs. NOAC (CATALYST)

Stroke | Atrial Fibrillation | Bleeding

United States, Australia, Netherlands, Denmark, Spain, Poland, France, Hong Kong, Switzerland, Germany, Japan, Czechia, Canada, Italy, United Kingdom, Lithuania
China National Center for Cardiovascular Diseases

Recruiting

Cerebral Microembolization Associated With PFO Closure

Thrombosis Cardiac

China
Abbott Medical Devices

Completed

Closure of Muscular Ventricular Septal Defects With The AMPLATZER™ Muscular VSD Occluder

Heart Septal Defects, Ventricular

United States
Abbott Medical Devices

No longer available

Emergency/Compassionate Use - Membranous VSD Occluder

Membranous | Ventricular | Septal | Defects | VSD
Lifetech Scientific (Shenzhen) Co., Ltd.

Completed

Post Market Clinical Follow-up Study of IrisFITTM PFO (Patent Foramen Ovale) Occluder (PFO)

Patent Foramen Ovale

Ireland, Germany
Abbott Medical Devices

Completed

Closure Of Patent Ductus Arteriosus With the AMPLATZER Duct Occluder the AMPLATZER® Duct Occluder

Patent Ductus Arteriosus (PDA)

United States
Occlutech International AB

Active, not recruiting

The PROOF Trial - Prospective, Open-label, Multicenter, Non-randomized Investigation on Percutaneous Patent Foramen Ovale (PFO) Closure Using the Occlutech PFO Occluder to Prevent Recurrence of Stroke in Patients With Cryptogenic Stroke and High Risk PFO (PROOF)

Stroke | PFO - Patent Foramen Ovale

France, Germany, Italy, Canada
Abbott Medical Devices

Recruiting

Amplatzer Amulet China Post Market Study (PMS)

Non-Valvular Atrial Fibrillation

China
Abbott Medical Devices

Completed

Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial

Cryptogenic Stroke

United States, Canada
Hangzhou Dinova EP Technology Co., Ltd

Not yet recruiting

Study on the Safety and Effectiveness of the SnowyTM PFO Closure System

Patent Foramen Ovale

China
SeptRx, Inc.

Unknown

InterSEPT: In-Tunnel SeptRx European PFO Trial (InterSEPT)

Heart Septal Defects | Heart Defects, Congenital | Foramen Ovale, Patent

Germany, France
Eclipse Medical Ltd.
KCRI

Recruiting

Evaluation od Safety and Performance of the Omega™ LAA (Left Atrial Appendage) Occluder and Omega™ Delivery System in Patients With Non-Valvular Atrial Fibrillation and High Bleeding Risk (Omega)

Non-Valvular Atrial Fibrillation

Denmark, Germany, Italy, Spain, United Kingdom
Lifetech Scientific (Shenzhen) Co., Ltd.

Completed

Lifetech KONAR MFO Post-Market Clinical Follow-Up Study

Ventricular Septal Defect

Italy, Germany
W.L.Gore & Associates

Recruiting

GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study (REDUCE PAS)

Stroke | PFO - Patent Foramen Ovale

United States
Cardiac Children's Foundation Taiwan

Recruiting

Cera™ VSD Occluder Post Market Clinical Follow-up

Ventricular Septal Defect

Taiwan
Vascular Innovations Co. Ltd.
MedPass International

Completed

Omega™ Left Atrial Appendage (LAA) Occluder in Patients With Non-Valvular Atrial Fibrillation

Atrial Fibrillation

Denmark, Thailand
Abbott Medical Devices

Completed

AMPLATZER™ Cardiac Plug Observational Post-Approval Study (ACP China)

Non-valvular Atrial Fibrillation (NVAF)

China
Lifetech Scientific (Shenzhen) Co., Ltd.

Recruiting

Safety and Efficacy of Cera™ Patent Foramen Ovale Occluders.

Patent Foramen Ovale | Cryptogenic Stroke

China
pfm medical ag
MDT Medical Device Testing GmbH

Completed

Procedural Success and Safety of the Nit-Occlud® Patent Foramen Ovale (PFO) Closure Device and Its Application System (09k003)

Heart Septal Defects, Atrial | Foramen Ovale, Patent | Heart Catheterization

Germany
Karolinska Institutet
Abbott Medical Devices

Recruiting

Prevention of Stroke by Left Atrial Appendage Closure in Atrial Fibrillation Patients After Intracerebral Hemorrhage

Stroke | Atrial Fibrillation | Intracerebral Hemorrhage

Denmark, Norway, Finland, Sweden
Jae-Kwan Song

Unknown

Device Closure Versus Medical Therapy for Cryptogenic Stroke Patients With High-Risk Patent Foramen Ovale (DEFENSE-PFO)

Patent Foramen Ovale

Korea, Republic of
Coherex Medical

Terminated

The Coherex FlatStent™ EF PFO Migraine Registry

Patients With Migraine and PFO
Lifetech Scientific (Shenzhen) Co., Ltd.

Withdrawn

Safety and Efficacy of IrisFIT™ Patent Foramen Ovale Occluders

Patent Foramen Ovale | Cryptogenic Stroke

China
Medtronic Cardiovascular

Active, not recruiting

FORWARD PRO Study Interventional Post-market Study With the Evolut™ PRO System

Aortic Valve Stenosis

Netherlands, France, Italy, Germany, Spain, Denmark, Belgium, United Kingdom, Slovenia, Finland, Austria, Israel, Norway, Switzerland
Hangzhou Dinova EP Technology Co., Ltd

Active, not recruiting

Evaluation of the Safety and Efficacy of a Novel SeaLA™ Left Atrial Appendage Occluder

Atrial Fibrillation

China
Medtronic Cardiovascular

Active, not recruiting

Optimize PRO Study

Symptomatic Aortic Stenosis

Canada, United States, Sweden, Israel, Germany, Belgium, United Kingdom, Australia, Italy, Ireland, France, Spain
Medtronic Cardiovascular

Active, not recruiting

Evolut PRO China Clinical Study

Severe, Symptomatic Aortic Stenosis

China

Search clinical trials for: AMPLATZER™ PFO Occluder

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Pakistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations